Standout Papers

Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer 2005 2026 2012 2019 2.4k
  1. Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer (2006)
    Charles E. Geyer, Deborah Lindquist et al. New England Journal of Medicine
  2. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group. (2005)
    Michel Marty, Francesco Cognetti et al. IRIS UNIMORE (University of Modena and Reggio Emilia)
  3. RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer (2011)
    Nicholas J. Robert, Véronique Dièras et al. Journal of Clinical Oncology

Immediate Impact

11 by Nobel laureates 4 from Science/Nature 106 standout
Sub-graph 1 of 19

Citing Papers

Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout
N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer
2022 Standout
15 intermediate papers

Works of Stephen Chan being referenced

Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
2006 Standout
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.
2005 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
Stephen Chan 7291 3703 2657 192 10.9k
Ingrid A. Mayer 5832 4896 3285 207 11.6k
Kimberly Blackwell 5876 2095 1844 139 8.9k
Jean-­Marc Ferrero 6284 1795 2928 207 9.3k
Joan Albanell 7586 4709 2674 248 12.1k
Nuhad K. Ibrahim 6209 2753 3866 143 9.8k
Herbert A. Fritsche 5608 3329 3848 159 10.9k
Steven J. Isakoff 4922 3873 2760 174 9.0k
Young‐Hyuck Im 8436 2824 3677 265 11.9k
Sarat Chandarlapaty 5812 6188 2878 201 12.2k
Federico Rojo 7491 6966 2523 263 13.2k

All Works

Loading papers...

Rankless by CCL
2026